» Articles » PMID: 35538816

Update on Etiology and Pathogenesis of Biliary Atresia

Overview
Specialty Pediatrics
Date 2022 May 11
PMID 35538816
Authors
Affiliations
Soon will be listed here.
Abstract

Biliary atresia is a rare inflammatory sclerosing obstructive cholangiopathy that initiates in infancy as complete choledochal blockage and progresses to the involvement of intrahepatic biliary epithelium. Growing evidence shows that biliary atresia is not a single entity with a single etiology but a phenotype resulting from multifactorial events whose common path is obliterative cholangiopathy. The etiology of biliary atresia has been explained as resulting from genetic variants, toxins, viral infection, chronic inflammation or bile duct lesions mediated by autoimmunity, abnormalities in the development of the bile ducts, and defects in embryogenesis, abnormal fetal or prenatal circulation and susceptibility factors. It is increasingly evident that the genetic and epigenetic predisposition combined with the environmental factors to which the mother is exposed are potential triggers for biliary atresia. There is also an indication that a progressive thickening of the arterial middle layer occurs in this disease, suggestive of vascular remodeling and disappearance of the interlobular bile ducts. It is suggested that the hypoxia/ischemia process can affect portal structures in biliary atresia and is associated with both the extent of biliary proliferation and the thickening of the medial layer.

Citing Articles

Structural Disruption of Cilia and Increased Cytoplasmic Tubulin in Biliary Atresia-An Exploratory Study Focusing on Early Postoperative Prognosis Following Portoenterostomy.

Quelhas P, Oliveira R, Kieling C, Vieira S, Dos Santos J Biomedicines. 2025; 13(1).

PMID: 39857671 PMC: 11763231. DOI: 10.3390/biomedicines13010087.


Microcystin-RR is a biliary toxin selective for neonatal extrahepatic cholangiocytes.

Gupta K, Chen D, Wells R JHEP Rep. 2024; 7(1):101218.

PMID: 39687604 PMC: 11648759. DOI: 10.1016/j.jhepr.2024.101218.


Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications.

Zhao J, Yue P, Mi N, Li M, Fu W, Zhang X Med Rev (2021). 2024; 4(4):326-365.

PMID: 39135601 PMC: 11317084. DOI: 10.1515/mr-2024-0029.


Systematic review of the mechanism and assessment of liver fibrosis in biliary atresia.

Zhan J, Liu S, Meng Y, Yang Q, Wang Z, Zhang S Pediatr Surg Int. 2024; 40(1):205.

PMID: 39033225 DOI: 10.1007/s00383-024-05778-x.


Exploring causality with biliary atresia at different levels: two-sample Mendelian randomization study.

Liu S, Musha J, Wang Z, Wang X, Li T, Zhan J World J Pediatr Surg. 2024; 7(2):e000754.

PMID: 38737962 PMC: 11086552. DOI: 10.1136/wjps-2023-000754.